TM4SF5 and metabolic dysfunction-associated steatotic liver disease: Genetically engineered mice with altered <i>Tm4sf5</i> and <i>Nrf2</i> displayed TM4SF5-induced MASLD phenotypes characterized by elevated Keap1, regardless of Nrf2 expression or activity.